Acrongenomics, Inc. (OTCBB:AGNM) is a publicly traded company that focuses on investing in and commercializing novel technology platforms concerning the Life Sciences Sector. "The company has entered into a joint development agreement with Molecular Vision whereby the company has been granted an exclusive, worldwide, perpetual license (including the right to sub-license) of the Background Intellectual Property and Results to develop, use, market, sell, supply and/or commercialize the technology". Acrongenomics brings novel and realistic concepts to market by transforming scientific innovations into tangible, consumer-oriented applications.

more about us